Loading...

Compugen Ltd.

CGEN•NASDAQ
Healthcare
Biotechnology
$2.89
$0.01(0.35%)
U.S. Market opens in 0h 23m

Compugen Ltd. (CGEN) Stock Overview

Explore Compugen Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap273.3M
P/E Ratio7.62
EPS (TTM)$0.38
ROE0.56%
Fundamental Analysis

AI Price Forecasts

1 Month$1.52
3 Months$1.49
1 Year Target$1.48

CGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Compugen Ltd. (CGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 78.71, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $1.48.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 7.62 and a market capitalization of 273.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.35%
5-Day Change
16.53%
1-Month Change
29.02%
3-Month Change
36.97%
6-Month Change
40.29%
Year-to-Date (YTD) Change
88.89%
1-Year Change
109.42%
3-Year Change
351.56%
5-Year Change
-67.53%
All-Time (Max) Change
-74.02%

Contact Information

https://cgen.com
972 3 765 8585
Azrieli Center, Holon, NaN, 5885849

Company Facts

74 Employees
IPO DateAug 11, 2000
CountryIL
Actively Trading

Frequently Asked Questions